4//SEC Filing
Hindman Andrew A. 4
Accession 0001415889-21-005466
CIK 0001583107other
Filed
Nov 22, 7:00 PM ET
Accepted
Nov 23, 8:22 PM ET
Size
5.1 KB
Accession
0001415889-21-005466
Insider Transaction Report
Form 4
Hindman Andrew A.
SVP, Chief Financial Officer
Transactions
- Tax Payment
Ordinary Shares
2021-11-19$8.36/sh−1,350$11,286→ 167,258 total
Footnotes (2)
- [F1]Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.
- [F2]Includes 1228 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on November 15, 2021.
Documents
Issuer
Theravance Biopharma, Inc.
CIK 0001583107
Entity typeother
Related Parties
1- filerCIK 0001607965
Filing Metadata
- Form type
- 4
- Filed
- Nov 22, 7:00 PM ET
- Accepted
- Nov 23, 8:22 PM ET
- Size
- 5.1 KB